BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 27
• 28

• Pharm Country

  Regeneron Pharmaceuticals, Inc. Release: EYLEA® (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion

  December 6, 2012

   · 

  10 min read
• Drug Development

  Naurex Inc. Release: Phase II Data Presented at ACNP 2012 Shows Novel Antidepressant GLYX-13 Significantly Reduces Depression Scores Within Hours

  December 6, 2012

   · 

  4 min read
• Business

  Dr. Peter Diamandis Joins Tribogenics Advisory Board

  December 6, 2012

   · 

  3 min read
• Pharm Country

  Cantel Medical Reports EPS of $0.35 vs. $0.23 for First Quarter Ended October 31, 2012

  December 6, 2012

   · 

  1 min read
• FDA

  Mauna Kea Technologies Obtains CE Mark for First Cellvizio Optical Biopsy Probe

  December 6, 2012

   · 

  5 min read
• Drug Development

  Omeros Corporation Announces Encouraging Data From Phase 1 Clinical Trial for PDE10 Program

  December 6, 2012

   · 

  3 min read
• Biotech Bay

  DURECT Corporation Announces Pricing of Public Offering of Common Stock

  December 6, 2012

   · 

  2 min read
• Business

  Albany Molecular Research, Inc. (AMRI) Extends Long Term Supply Relationship With GE Healthcare

  December 6, 2012

   · 

  3 min read
• Biotech Beach

  InVivoScribe Technologies, Inc. Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire Clinically-Actionable Genetic Test Menu

  December 6, 2012

   · 

  4 min read
• Quebec Clinic Launches Canadian Use of Elekta’s Agility Beam-Shaping Innovation for Radiation Therapy of Cancer

  December 6, 2012

   · 

  3 min read